Back to companies
HALOZYME THERAPEUTICS, INC.
HALOUSNASDAQPharmaceuticals & HealthcareHALOZYME THERAPEUTICS, INC.
Revenue
$1.4bn
YoY +37.6%
Operating income
$469.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API